MBMS—IP Multicast/Broadcast in 3G Networks

In this article, the Multimedia Broadcast and Multicast Service (MBMS) as standardized in 3GPP is presented. With MBMS, multicast and broadcast capabilities are introduced into cellular networks. After an introduction into MBMS technology, MBMS radio bearer realizations are presented. Different MBMS bearer services like broadcast mode, enhanced broadcast mode and multicast mode are discussed. Streaming and download services over MBMS are presented and supported media codecs are listed. Service layer components as defined in Open Mobile Alliance (OMA) are introduced. For a Mobile TV use case capacity improvements achieved by MBMS are shown. Finally, evolution of MBMS as part of 3GPP standardization is presented

Advanced control strategies for the continuous production of monoclonal antibodies

Please click Additional Files below to see the full abstract. Please click Download on the upper right corner to see the presentation

Mid-term results of a modified arterial switch operation using the direct reconstruction technique of the pulmonary artery

Background: There is ongoing discussion as to whether it is beneficial to avoid pulmonary sinus augmentation in the arterial switch operation. We report a single-surgeon series of mid-term results for direct pulmonary artery anastomosis during switch operation for transposition of the great arteries (TGA). Methods: This retrospective study includes 17 patients with TGA, combined with an atrial septal defect, patent foramen ovale or ventricular septal defect. Patient data was analyzed from hospital charts, including operative reports, post-operative course, and regular follow-up investigations. The protocol included cardiological examination by a single pediatric cardiologist. Echocardiographic examinations were performed immediately after arrival on the intensive unit, before discharge, and then after three, six, and 12 months, followed by yearly intervals. Pulmonary artery stenosis (PAS) was categorized into three groups according to the Doppler-measured pulmonary gradient: grade I (trivial stenosis) = increased pulmonary flow with a gradient below 25 mm Hg; grade II (moderate stenosis) = a gradient ranging from 25 to 49 mm Hg; and grade III (severe stenosis) = a gradient above 50 mm Hg. Follow-up data was available for all patients. The length of follow-up ranged from 1.2 to 9.7 years, median: 7.5 years (mean 6.1 years ± 14 months). Results: During follow-up, 12 patients (70.6%) had no (or only trivial) PAS, five patients (29.4%) had moderate stenosis without progress, and no patient had severe PAS. Cardiac catheterization after arterial switch operation was performed in 11 patients (64.7%) and showed a good correlation with echocardiographic findings. During follow-up there was no reintervention for PAS. Conclusions: Direct reconstruction of the neo-pulmonary artery is a good option in TGA with antero-posterior position of the great vessels, with very satisfactory mid-term results. (Cardiol J 2010; 17, 6: 574-579

Integration of a Vehicle Operating Mode Management into UNICARagil’s Automotive Service-oriented Software Architecture

Automated vehicles require a central decision unit in order to coordinate the responsibility for the driving task between multiple operating modes. Additionally, other nondriving related tasks such as operation of an automatic door system must be coordinated as well. In this paper, we will motivate the usefulness of such a central decision unit at the example of the operating mode management of the UNICARagil project. We will describe its integration with UNICARagil’s Automotive Service-oriented Software Architecture and how modularity of this service-oriented software architecture is ensured. An example from the project’s context will further illustrate the functioning principle of the operating mode management in combination with the service orchestration of the Automotive Service-oriented Software Architecture

Laser power stabilization for improved ablation depth uniformity

Due to low heat deposition into the surrounding material, ps-lasers are well suited for a precise ablation of micro structures. However, to obtain constant removal rates the laser parameters as well as the environmental conditions need to be kept stable. For our investigations we used a frequency tripled ps-laser operating at 355 nm. Without any additional power stabilization system, long term micro structuring processes of OFE-copper typically resulted in depth variations of about +/- 10 % which are strongly correlated with detected laser power fluctuations. The developed system for laser power stabilization takes advantage of the linear polarized radiation of our laser source. With a fast photoelectric detector the power fluctuations are measured. A specifically designed feedback control system turns a half wave plate mounted in a piezo driven rotation stage to decouple fluctuating power fractions via a polarizing beam splitter. We demonstrate a nearly constant laser power at the work piece. Substantially improved ablation depth uniformity is verified by a profilometric analysis of directly ablated diffractive structures

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?

Simple Summary V domain immunoglobulin suppressor of T cell activation (VISTA) has recently been described as a protein expressed on immune cells and tumour cells and a possible target for immunotherapy. We show for the first time that VISTA is broadly expressed across subtypes of soft tissue sarcoma. We found VISTA related to other immunopathological parameters such as tumour-infiltrating lymphocytes and observed improved survival in patients with non-T-cell-inflamed tumours expressing VISTA. Our research supports the notion of VISTA as a potential target for immunotherapy in soft tissue sarcoma. Abstract (1) Background: V domain immunoglobulin suppressor of T cell activation (VISTA) plays a critical role in antitumor immunity and may be a valuable target in cancer immunotherapy. To date, it has never been studied in a large and well-characterised cohort of soft tissue sarcomas (STS). (2) Methods: Using immunohistochemistry, we examined VISTA expression in tumour tissues of 213 high-risk STS. We then analysed whether VISTA was associated with other clinicopathological parameters, including tumour-infiltrating lymphocyte (TIL) counts, programmed death receptor-1 (PD1), programmed death ligand-1 (PDL1), CD3, grading, and long-term survival. (3) Results: We observed VISTA expression in 96 (45%) of 213 specimens with distinct patterns ranging from 26 to 63% for histological subtypes. VISTA was associated with higher grade (G3 vs. G2, p = 0.019), higher TIL counts ( p = 0.033), expression of PD1 ( p = 0.046), PDL1 ( p = 0.031), and CD3+ ( p = 0.023). In patients without CD3 + TILs, 10-year survival was higher when VISTA was expressed compared to when there was no VISTA expression ( p = 0.013). In a multivariate analysis, VISTA expression was independently associated with prolonged survival ( p = 0.043). (4) Conclusions: VISTA is expressed in different STS subtypes and is associated with increased TILs, PD-1, PD-L1, and CD3 expression. Patients with VISTA + tumours show improved survival. These results may help define future immunotherapeutic approaches in STS

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma

(1) Background: PRAME, NY-ESO-1, and SSX2 are cancer testis antigens (CTAs), which are expressed in testicular germ cells with re-expression in numerous cancer types. Their ability to elicit humoral and cellular immune responses have rendered them promising targets for cancer immunotherapy, but they have never been studied in a large and well-characterised cohort of soft tissue sarcomas (STS). (2) Methods: On a protein level, we examined PRAME, NY-ESO-1, and SSX2 expression in tumour tissues of 249 high-risk STS using immunohistochemistry. We correlated expression levels with clinicopathological parameters including tumour-infiltrating lymphocyte (TIL) counts, grading, and long-term survival. (3) Results: Expression of PRAME, NY-ESO-1, and SSX2 was observed in 25 (10%), 19 (8%), and 11 (4%) of 249 specimens with distinct patterns for histo-subtypes. Expression of PRAME was associated with shorter patient survival (p = 0.005) and higher grade (G2 vs. G3, p = 0.001), while NY-ESO-1 expression was correlated with more favourable survival (p = 0.037) and lower grade (G2 vs. G3, p = 0.029). Both PRAME and NY-ESO-1 expression were more frequent in STS with low TIL counts. In multivariate analysis, high PRAME and low SSX2 expression levels as well as metastatic disease and non-radical resections were independent predictors of shorter overall survival. (4) Conclusions: CTAs PRAME, NY-ESO-1, and SSX2 show distinct expression patterns in different STS subtypes. These results demonstrate their prognostic relevance and may guide future immunotherapeutic approaches in STS

BEER - The Beamline for European Materials Engineering Research at the ESS

The Beamline for European Materials Engineering Research (BEER) will be built at the European Spallation Source (ESS). The diffractometer utilizes the high brilliance of the long-pulse neutron source and offers high instrument flexibility. It includes a novel chopper technique that extracts several short pulses out of the long pulse, leading to substantial intensity gain of up to an order of magnitude compared to pulse shaping methods for materials with high crystal symmetry. This intensity gain is achieved without compromising resolution. Materials of lower crystal symmetry or multi-phase materials will be investigated by additional pulse shaping methods. The different chopper set-ups and advanced beam extracting techniques offer an extremely broad intensity/resolution range. Furthermore, BEER offers an option of simultaneous SANS or imaging measurements without compromising diffraction investigations. This flexibility opens up new possibilities for in-situ experiments studying materials processing and performance under operation conditions. To fulfil this task, advanced sample environments, dedicated to thermo-mechanical processing, are foreseen

The latch modulates nucleotide and DNA binding to the helicase-like domain of Thermotoga maritima reverse gyrase and is required for positive DNA supercoiling

Reverse gyrase is the only topoisomerase that can introduce positive supercoils into DNA in an ATP-dependent process. It has a modular structure and harnesses a helicase-like domain to support a topoisomerase activity, thereby creating the unique function of positive DNA supercoiling. The isolated topoisomerase domain can relax negatively supercoiled DNA, an activity that is suppressed in reverse gyrase. The isolated helicase-like domain is a nucleotide-dependent switch that is attenuated by the topoisomerase domain. Inter-domain communication thus appears central for the functional cooperation of the two domains. The latch, an insertion into the helicase-like domain, has been suggested as an important element in coordinating their activities. Here, we have dissected the influence of the latch on nucleotide and DNA binding to the helicase-like domain, and on DNA supercoiling by reverse gyrase. We find that the latch is required for positive DNA supercoiling. It is crucial for the cooperativity of DNA and nucleotide binding to the helicase-like domain. The latch contributes to DNA binding, and affects the preference of reverse gyrase for ssDNA. Thus, the latch coordinates the individual domain activities by modulating the helicase-like domain, and by communicating changes in the nucleotide state to the topoisomerase domain